Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Williams-Sonoma, Inc. — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.06 (market cap $2.86B), while Williams-Sonoma, Inc. trades at $243.14 (market cap $28.26B). The key difference: Williams-Sonoma, Inc. is far larger — about 9.9× Dyne Therapeutics Inc. Common Stock's market cap, and Williams-Sonoma, Inc. pays a 1.27% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Williams-Sonoma, Inc. for 59 Days on average.
| DYN | WSM | |
|---|---|---|
Market Cap | $2.86B | $28.26B |
Volume | 3,341,579 | 1,108,410 |
Sector | Health | Consumer Cyclical |
52-Week High | $26.78 | $251.81 |
52-Week Low | $14.60 | $168.64 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $2.18B | $28.76B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Williams-Sonoma (WSM) trades at $242.48, up 1.52% recently, with a bullish technical outlook and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Profitability remains robust, with a net income margin of 14.73% and ROE of 54.96%, while valuation ratios like P/E of 24.61 and P/S of 3.62 reflect market confidence. Recent news highlights growth through minimal discounting and AI integration, supporting positive sentiment.
The outlook for WSM is favorable, driven by earnings momentum and market share gains, but risks include housing market sensitivity and competitive pressures. Analyst consensus leans hold with a $246.31 price target, suggesting modest upside. Institutional interest is steady, though insider selling warrants monitoring. Overall, the stock presents a balanced opportunity with growth potential tempered by sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
